Guidance ledger · Q4 FY26

Tube Investments of India Ltd TIINDIA

3 revisions on record · 0 lowered · 2 raised — the strikethrough is what management used to say

directional guidance only · shifted across quarters

Holding view → · latest concall · The pulse

↑ raised TI Medical growth target Q2 FY26 → Q4 FY26

~~15% plus surgical (softened from 20-25%)~~ → 20% year-on-year overall

“we are hopeful will give 20% year-on-year growth in TI Medical going forward.”

→ narrowed Core business capex FY27 Q2 FY26 → Q4 FY26

~~Rs.300 to Rs.400 Crores~~ → Rs.300 to Rs.350 Crores

“capex in our core business will be around Rs.300 Crores to Rs.350 Crores range.”

↑ raised CDMO commercial production start Q3 FY26 → Q4 FY26

~~Deferred — Q3FY26 no update~~ → Q1 FY27 from Naidupet facility

“we are going to do the commercial production from our Naidupet facility starting next quarter.”

Method. Revisions come from management's own stated numbers, compared quarter over quarter across the covered concalls; each carries the verbatim quote. “No revisions” can also mean guidance too vague to pin down — see the posture chip above. Not investment advice.